The mechanism of honokiol-induced and magnolol-induced inhibition on muscle contraction and Ca2+ mobilization in rat uterus

Naunyn Schmiedebergs Arch Pharmacol. 2003 Oct;368(4):262-9. doi: 10.1007/s00210-003-0802-8. Epub 2003 Sep 18.

Abstract

The effects of honokiol and magnolol extracted from the Magnolia officinalis on muscular contractile responses and intracellular Ca(2+) mobilization were investigated in the non-pregnant rat uterus. Honokiol and magnolol (1-100 micromol/l) were observed to inhibit spontaneous and uterotonic agonists (carbachol, PGF(2alpha), and oxytocin)-, high K(+)-, and Ca(2+) channel activator (Bay K 8644)-induced uterine contractions in a concentration-dependent manner. The inhibition rate of honokiol on spontaneous contractions appeared to be slower than that of magnolol-induced response. The time periods that were required for honokiol and magnolol, at 100 micromol/l, to abolish 50% spontaneous contractions were approximately 6 min. Furthermore, honokiol and magnolol at 10 micromol/l also blocked the Ca(2+)-dependent oscillatory contractions. Consistently, the increases in intracellular Ca(2+) concentrations ([Ca(2+)](i)) induced by PGF(2alpha) and high K(+) were suppressed by both honokiol and magnolol at 10 micromol/l. After washout of these treatments, the rise in [Ca(2+)](i) induced by PGF(2alpha) and high K(+) was still partially abolished. In conclusion, the inhibitory effects of honokiol and magnolol on uterine contraction may be mediated by blockade of external Ca(2+) influx, leading to a decrease in [Ca(2+)](i). Honokiol and magnolol may be considered as putative Ca(2+) channel blockers and be of potential value in the treatment of gynecological dysfunctions associated with uterine muscular spasm and dysmenorrhea.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biphenyl Compounds / pharmacology*
  • Calcium / metabolism*
  • Carbachol / pharmacology
  • Central Nervous System Depressants / pharmacology*
  • Dinoprost / pharmacology
  • Female
  • Fluorescent Dyes
  • Fura-2
  • In Vitro Techniques
  • Lignans*
  • Muscarinic Agonists / pharmacology
  • Myometrium / drug effects
  • Myometrium / metabolism
  • Oxytocics / pharmacology
  • Oxytocin / pharmacology
  • Potassium Chloride / pharmacology
  • Rats
  • Uterine Contraction / drug effects*
  • Uterus / drug effects
  • Uterus / metabolism*

Substances

  • Biphenyl Compounds
  • Central Nervous System Depressants
  • Fluorescent Dyes
  • Lignans
  • Muscarinic Agonists
  • Oxytocics
  • magnolol
  • honokiol
  • Oxytocin
  • Potassium Chloride
  • Carbachol
  • Dinoprost
  • Calcium
  • Fura-2